InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Ford Kathleen, Chief Operating Officer. Director active across 1 company, notably Kura Oncology, Inc.. Cumulatively, 10 disclosures have been recorded. Breakdown: 0 buy · 6 sells. Total volume traded: €91k. History available since 26 January 2022. The latest transaction was filed on 27 January 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Ford Kathleen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
1,813 shares@ US$8.460714.2% of flowCommon StockSEC:0001193125-26-025304:0
50,000 shares0Common StockSEC:0001193125-26-004567:0
48,900 shares0Common StockSEC:0001193125-25-283560:0
48,900 shares0Common StockSEC:0001193125-25-223665:0
1,558 shares@ US$6.275611.1% of flowCommon StockSEC:0000950170-25-074659:0
1,817 shares@ US$7.871917.5% of flowCommon StockSEC:0000950170-25-010118:0
526 shares@ US$16.033710.2% of flowCommon StockSEC:0000950170-24-128558:0
1,496 shares@ US$17.800531.4% of flowCommon StockSEC:0000950170-24-009494:0
1,821 shares@ US$13.890129.7% of flowCommon StockSEC:0001209191-23-005753:0
21,900 shares0Common StockSEC:0001209191-22-005380:0
10 of 10 declarations
About Ford Kathleen
Kathleen Ford is the Chief Operating Officer at Kura Oncology, Inc. In this role, she oversees the company's daily operations and is responsible for implementing the operational strategy. Ford plays a key role in improving operational efficiency and managing resources. Her expertise in operations management is essential to ensure that Kura Oncology meets its objectives.
